The University of Chicago Header Logo

Connection

Olwen Hahn to Receptors, Glucocorticoid

Back to Details
This is a "connection" page, showing publications Olwen Hahn has written about Receptors, Glucocorticoid.
Olwen Hahn
Connection Strength
0.050
Receptors, Glucocorticoid
  1. A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer. Breast Cancer Res Treat. 2025 May; 211(1):111-119.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.